The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2013;(4): 10‑16

Read: 980 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2013;(4):10‑16. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. O'Gara P.T., Kushner F.G., Ascheim D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-e425.
  2. Steg P.G., James S.K., Atar D., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
  3. Krumholz H.M., Wang Y., Chen J., et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA. 2009;302:767-773.
  4. Larose E., Rodés-Cabau J., Pibarot P., et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardio-vascular magnetic resonance. J Am Coll Cardiol 2010;55:2459-2469.
  5. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-175.
  6. Sommers H.M., Jennings R.B. Ventricular fibrillation and myocardial necrosis after transient ischemia: effect of treatment with oxygen, procain-amide, reserpine, and propranolol. Arch Intern Med. 1972;129:780-789.
  7. Hearse D.J., Yellon D.M., Downey J.M. Can beta blockers limit myocardial infarct size? Eur Heart J 1986;7:925-930.
  8. Metoprolol in Acute Myocardial Infarction (MIAMI): a randomised pla- cebo-controlled international trial: the MIAMI Trial Research Group. Eur Heart J 1985;6:199-226.
  9. Yusuf S., Sleight P., Rossi P., et al. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983;67(pt 2):I32-I41.
  10. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med 1984;310:9-15.
  11. Rude R.E., Buja L.M., Willerson J.T. Propranolol in acute myocardial infarction: the MILIS experience. Am J Cardiol 1986;57:38F-42F.
  12. Van de Werf F., Janssens L., Brzostek T., et al. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 1993;22:407-416.
  13. Risenfors M., Herlitz J., Berg C.H., et al. Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study. J Intern Med Suppl 1991;734:35-42.
  14. Ibanez B., Prat-González S., Speidl W.S., et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007;115:2909-2916.
  15. Ibanez B., Cimmino G., Prat-González S., et al. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol 2011;147:428-432.
  16. Wu E., Ortiz J.T., Tejedor P., et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008;94:730-736.
  17. Prasad A., Stone G.W., Aymong E., et al. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J 2004;147:669-675.
  18. Solis P., Amsterdam E.A., Bufalino V., et al. Development of systems of care for ST-elevation myocardial infarction patients: policy recommendations. Circulation 2007;116:e73-e76.
  19. Kloner R.A., Hale S.L., Dai W., et al. Reduction of ischemia/reperfusion injury with benda- via, a mitochondria-targeting cytoprotective peptide. J Am Heart Assoc 2012;1:e001644.
  20. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
  21. Gerczuk P.Z., Kloner R.A. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012;59:969-978.
  22. Rasmussen M.M., Reimer K.A., Kloner R.A., Jennings R.B. Infarct size reduction by propranolol before and after coronary ligation in dogs. Circulation 1977;56:794-798.
  23. Hjalmarson A., Armitage P., Chamberlain D., et al. Metoprolol in acute myocardial-infarction (MIAMI): a randomized placebo-controlled international trial. Eur Heart J 1985;6:199-226.
  24. Yusuf S., Sleight P., Rossi P., et al. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983;67(pt 2):I32-I41.
  25. Hjalmarson A., Herlitz J., Malek I., et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet 1981;2:823-827.
  26. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial-infarction: ISIS-1. Lancet1986;2:57-66.
  27. Roberts R., Rogers W.J., Mueller H.S., et al. Immediate versus deferred beta-blockade follow- ing thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B study. Circulation 1991;83:422-437.
  28. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1622-1632.
  29. Halkin A., Grines C.L., Cox D.A., et al. Impact of intravenous beta-blockade before primary angio- plasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 2004;43:1780-1787.
  30. Valle J.A., Zhang M., Dixon S., et al. Impact of pre-procedural beta blockade on inpatient mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol 2013;111:1714-1720.
  31. Sharma S.K., Kini A., Marmur J.D., Fuster V. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation 2000;102:166-172.
  32. Ellis S.G., Brener S.J., Lincoff A.M., et al. Beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation 2001;104:2685-2688.
  33. Hanada K., Higuma T., Nishizaki F., et al. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting beta 1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 2012;76:439-445.
  34. Ndrepepa G., Kastrati A. Intravenous Β-Blockers in Primary Percutaneous Coronary Intervention: New Hope for an Old Therapy. Circulation 2013;128:1487-1489.
  35. Díaz R., Goyal A., Mehta S.R., et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 2007;298:2399-2405.
  36. Desmet W., Bogaert J., Dubois C., et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 2011;32:867-877.
  37. Bush L.R., Buja L.M., Tilton G., et al. Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. Circulation 1985;72:413-430.
  38. Campbell W.B., Johnson A.R., Callahan K.S., Graham R.M. Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet 1981;2:1382-1384.
  39. Pitt B., Craven P. Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc Res 1970;4:176-179.
  40. Mak I.T., Weglicki W.B. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988;63:262-266.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.